Request for Information on Research Opportunities Related to the National Institutes of Health Scientific Workshop on Violence and Related Health Outcomes in Sexual and Gender Minority Communities, 75343-75344 [2020-26094]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 228 / Wednesday, November 25, 2020 / Notices
MD 20892, (301) 594–4805, adombroski@
mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the urgent
need to meet timing limitations imposed by
the intramural research review cycle.
Information is also available on the
Institute’s/Center’s home page: https://
www.nidcr.nih.gov/about-us/advisorycommittees, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: November 20, 2020.
Patricia B. Hansberger,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2020–26109 Filed 11–24–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Request for Information on Research
Opportunities Related to the National
Institutes of Health Scientific
Workshop on Violence and Related
Health Outcomes in Sexual and
Gender Minority Communities
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
Through this Request for
Information (RFI), the Sexual & Gender
Minority Research Office (SGMRO) in
the Division of Program Coordination,
Planning, and Strategic Initiatives
(DPCPSI), Office of the Director (OD),
National Institutes of Health (NIH),
invites feedback from stakeholders
throughout the scientific research
community, clinical practice
communities, patient and family
advocates, scientific or professional
organizations, federal partners, internal
NIH stakeholders, and other interested
constituents on research opportunities
related to the upcoming NIH Scientific
Workshop on Violence and Related
Health Outcomes in Sexual and Gender
Minority (SGM) Communities. The
overarching purpose of this workshop is
to identify and prioritize key research
opportunities to further our
understanding of violence against SGM
individuals.
DATES: The SGMRO’s RFI is open for
public comment for a period of 8 weeks.
Comments must be received on or
before COB (5:00 p.m. E.T.) January 29,
2021, to ensure consideration. After the
public comment period has closed, the
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:27 Nov 24, 2020
Jkt 253001
comments received by SGMRO will be
considered in a timely manner and
shared with invitees to the Scientific
Workshop on Violence and Related
Health Outcomes in SGM Communities.
ADDRESSES: Please see the
supplementary information to view the
draft domains and themes of focus for
the Scientific Workshop on Violence
and Related Health Outcomes in SGM
Communities. It is strongly encouraged
to submit comments by email to
SGMRO@nih.gov. Please include ‘‘SGM
Health and Violence Workshop’’ in the
subject line.
FOR FURTHER INFORMATION CONTACT:
Irene Avila, Ph.D., Assistant Director,
Sexual & Gender Minority Research
Office (SGMRO), 6555 Rock Spring
Drive, Rm 2SE31J, Bethesda, MD 20817,
avilai@mail.nih.gov, 301–594–9701.
SUPPLEMENTARY INFORMATION:
Background: ‘‘Sexual and gender
minority’’ is an umbrella term that
includes, but is not limited to,
individuals who identify as lesbian, gay,
bisexual, asexual, transgender, TwoSpirit, queer, and/or intersex.
Individuals with same-sex or -gender
attractions or behaviors and those with
a difference in sex development are also
included. These populations also
encompass those who do not selfidentify with one of these terms but
whose sexual orientation, gender
identity or expression, or reproductive
development is characterized by nonbinary constructs of sexual orientation,
gender, and/or sex.
In accordance with Section 404N of
the 21st Century Cures Act (Pub. L. 114–
255), the Director of NIH shall
encourage research on SGM
populations. The Sexual and Gender
Minority Research Office (SGMRO)
coordinates sexual and gender minority
(SGM)–related research and activities by
working directly with NIH Institutes,
Centers, and Offices. The Office was
officially established in September 2015
within the DPCPSI in the NIH OD and
has the following operational goals: (1)
Advance rigorous research on the health
of SGM populations in both the
extramural and intramural research
communities; (2) expand SGM health
research by fostering partnerships and
collaborations with a strategic array of
internal and external stakeholders; (3)
foster a highly skilled and diverse
workforce in SGM health research; and
(4) encourage data collection related to
SGM populations in research and the
biomedical research workforce. The
Scientific Workshop on Violence and
Related Health Outcomes in Sexual and
Gender Minority Communities
represents an important step in
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
75343
pursuing these goals specifically in the
field of violence research.
Request for Comment on Research
Opportunities: NIH will be holding a
workshop to enhance our understanding
of violence against SGM individuals and
identify opportunities in violencerelated research. The SGMRO invites
input from stakeholders throughout the
scientific research community, clinical
practice communities, patient and
family advocates, scientific or
professional organizations, federal
partners, internal NIH stakeholders, and
other interested members of the public
on research opportunities related to the
four domains highlighted below. This
input will serve as a valuable element
in the development of the workshop and
subsequent report out, and the
community’s time and consideration are
highly appreciated.
This RFI serves as the first phase of
the Scientific Workshop on Violence
and Related Health Outcomes in Sexual
and Gender Minority Communities.
After the RFI has closed and comments
from the public have been reviewed by
workshop invitees, the second phase of
the workshop will take place. During
phase II, workshop invitees will discuss
the current landscape of violence
research, including an overview of
specific subsets of violence research,
relevant terminology, impacts on SGM
populations, and institutional contexts.
This phase will focus on four domains
of violence research:
• Family of origin abuse across the
lifespan, including child maltreatment
(sexual, physical, psychological, and
neglect) and elder abuse;
• Victimization by peers and friends,
including youth and adult peer
victimization (including bullying) and
cyberbullying (among both youths and
adults);
• Romantic and sexual partner
violence, including teen dating violence,
intimate partner violence, and sexual
violence; and
• Community violence, including
gender-based violence, hate crimes,
workplace violence, neighborhood
violence, and police violence.
In addition, relevant systemic and
institutional barriers will be considered
for each of these four areas.
In phase III, workgroups will be
formed to identify and describe central
themes and opportunities in violence
research, taking into consideration
feedback from the RFI. The workgroups
will comprise expert participants from
each of the four phase II sessions as well
as other key partners and stakeholders.
The four themes for workgroup
discussion will be:
E:\FR\FM\25NON1.SGM
25NON1
75344
Federal Register / Vol. 85, No. 228 / Wednesday, November 25, 2020 / Notices
• Socio-demographics and
epidemiology
• Risk factors and pathways
• Preventive strategies and
interventions
• Structural interventions
NIH seeks comments and/or
suggestions from all interested parties
on key research opportunities in SGM
health and violence.
Responses to this RFI are voluntary.
Do not include any proprietary,
classified, confidential, trade secret, or
sensitive information in your response.
The responses will be reviewed by NIH
staff, and individual feedback will not
be provided to any responder. The
Government will use the information
submitted in response to this RFI at its
discretion. The Government reserves the
right to use any submitted information
on public NIH websites; in reports; in
summaries of the state of the science; in
any possible resultant solicitation(s),
grant(s), or cooperative agreement(s); or
in the development of future funding
opportunity announcements.
This RFI is for information and
planning purposes only and should not
be construed as a solicitation for
applications or proposals, or as an
obligation in any way on the part of the
United States Federal Government, NIH,
or individual NIH Institutes, Centers,
and Offices to provide support for any
ideas identified in response to it. The
Federal Government will not pay for the
preparation of any information
submitted or for the Government’s use
of such information. No basis for claims
against the U.S. Government shall arise
as a result of a response to this RFI or
from the Government’s use of such
information. Additionally, the
Government cannot guarantee the
confidentiality of the information
provided.
Dated: November 18, 2020.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2020–26094 Filed 11–24–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jbell on DSKJLSW7X2PROD with NOTICES
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
VerDate Sep<11>2014
16:27 Nov 24, 2020
Jkt 253001
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Inherited
Disease Research Access Committee.
Date: January 8, 2021.
Time: 11:30 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700
B Rockledge Drive, Room 3185, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Barbara J. Thomas, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, National Institutes of Health, 6700
B Rockledge Drive, Room 3185, Bethesda,
MD 20892, 301–402–8837, barbara.thomas@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: November 19, 2020.
Patricia B. Hansberger,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2020–26110 Filed 11–24–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review: Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: SBIR/STTR Commercialization
Readiness Pilot Program.
Date: December 17, 2020.
Time: 11:00 a.m. to 12:00 p.m.
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Allen Richon, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6184,
MSC 7892, Bethesda, MD 20892, 301–379–
9351, allen.richon@nih.hhs.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: November 19, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–26031 Filed 11–24–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences: Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of Diversity Program
Consortium Sponsored Programs
Administration Development (SPAD)
Program applications.
Date: November 23, 2020.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Lisa A. Dunbar, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN12, Bethesda, MD
20892, (301) 594–2849, dunbarl@
mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
E:\FR\FM\25NON1.SGM
25NON1
]]>Agencies
[Federal Register Volume 85, Number 228 (Wednesday, November 25, 2020)]
[Notices]
[Pages 75343-75344]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-26094]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Request for Information on Research Opportunities Related to the
National Institutes of Health Scientific Workshop on Violence and
Related Health Outcomes in Sexual and Gender Minority Communities
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Through this Request for Information (RFI), the Sexual &
Gender Minority Research Office (SGMRO) in the Division of Program
Coordination, Planning, and Strategic Initiatives (DPCPSI), Office of
the Director (OD), National Institutes of Health (NIH), invites
feedback from stakeholders throughout the scientific research
community, clinical practice communities, patient and family advocates,
scientific or professional organizations, federal partners, internal
NIH stakeholders, and other interested constituents on research
opportunities related to the upcoming NIH Scientific Workshop on
Violence and Related Health Outcomes in Sexual and Gender Minority
(SGM) Communities. The overarching purpose of this workshop is to
identify and prioritize key research opportunities to further our
understanding of violence against SGM individuals.
DATES: The SGMRO's RFI is open for public comment for a period of 8
weeks. Comments must be received on or before COB (5:00 p.m. E.T.)
January 29, 2021, to ensure consideration. After the public comment
period has closed, the comments received by SGMRO will be considered in
a timely manner and shared with invitees to the Scientific Workshop on
Violence and Related Health Outcomes in SGM Communities.
ADDRESSES: Please see the supplementary information to view the draft
domains and themes of focus for the Scientific Workshop on Violence and
Related Health Outcomes in SGM Communities. It is strongly encouraged
to submit comments by email to [email protected]. Please include ``SGM
Health and Violence Workshop'' in the subject line.
FOR FURTHER INFORMATION CONTACT: Irene Avila, Ph.D., Assistant
Director, Sexual & Gender Minority Research Office (SGMRO), 6555 Rock
Spring Drive, Rm 2SE31J, Bethesda, MD 20817, [email protected], 301-
594-9701.
SUPPLEMENTARY INFORMATION:
Background: ``Sexual and gender minority'' is an umbrella term that
includes, but is not limited to, individuals who identify as lesbian,
gay, bisexual, asexual, transgender, Two-Spirit, queer, and/or
intersex. Individuals with same-sex or -gender attractions or behaviors
and those with a difference in sex development are also included. These
populations also encompass those who do not self-identify with one of
these terms but whose sexual orientation, gender identity or
expression, or reproductive development is characterized by non-binary
constructs of sexual orientation, gender, and/or sex.
In accordance with Section 404N of the 21st Century Cures Act (Pub.
L. 114-255), the Director of NIH shall encourage research on SGM
populations. The Sexual and Gender Minority Research Office (SGMRO)
coordinates sexual and gender minority (SGM)-related research and
activities by working directly with NIH Institutes, Centers, and
Offices. The Office was officially established in September 2015 within
the DPCPSI in the NIH OD and has the following operational goals: (1)
Advance rigorous research on the health of SGM populations in both the
extramural and intramural research communities; (2) expand SGM health
research by fostering partnerships and collaborations with a strategic
array of internal and external stakeholders; (3) foster a highly
skilled and diverse workforce in SGM health research; and (4) encourage
data collection related to SGM populations in research and the
biomedical research workforce. The Scientific Workshop on Violence and
Related Health Outcomes in Sexual and Gender Minority Communities
represents an important step in pursuing these goals specifically in
the field of violence research.
Request for Comment on Research Opportunities: NIH will be holding
a workshop to enhance our understanding of violence against SGM
individuals and identify opportunities in violence-related research.
The SGMRO invites input from stakeholders throughout the scientific
research community, clinical practice communities, patient and family
advocates, scientific or professional organizations, federal partners,
internal NIH stakeholders, and other interested members of the public
on research opportunities related to the four domains highlighted
below. This input will serve as a valuable element in the development
of the workshop and subsequent report out, and the community's time and
consideration are highly appreciated.
This RFI serves as the first phase of the Scientific Workshop on
Violence and Related Health Outcomes in Sexual and Gender Minority
Communities. After the RFI has closed and comments from the public have
been reviewed by workshop invitees, the second phase of the workshop
will take place. During phase II, workshop invitees will discuss the
current landscape of violence research, including an overview of
specific subsets of violence research, relevant terminology, impacts on
SGM populations, and institutional contexts. This phase will focus on
four domains of violence research:
Family of origin abuse across the lifespan, including
child maltreatment (sexual, physical, psychological, and neglect) and
elder abuse;
Victimization by peers and friends, including youth and
adult peer victimization (including bullying) and cyberbullying (among
both youths and adults);
Romantic and sexual partner violence, including teen
dating violence, intimate partner violence, and sexual violence; and
Community violence, including gender-based violence, hate
crimes, workplace violence, neighborhood violence, and police violence.
In addition, relevant systemic and institutional barriers will be
considered for each of these four areas.
In phase III, workgroups will be formed to identify and describe
central themes and opportunities in violence research, taking into
consideration feedback from the RFI. The workgroups will comprise
expert participants from each of the four phase II sessions as well as
other key partners and stakeholders. The four themes for workgroup
discussion will be:
[[Page 75344]]
Socio-demographics and epidemiology
Risk factors and pathways
Preventive strategies and interventions
Structural interventions
NIH seeks comments and/or suggestions from all interested parties
on key research opportunities in SGM health and violence.
Responses to this RFI are voluntary. Do not include any
proprietary, classified, confidential, trade secret, or sensitive
information in your response. The responses will be reviewed by NIH
staff, and individual feedback will not be provided to any responder.
The Government will use the information submitted in response to this
RFI at its discretion. The Government reserves the right to use any
submitted information on public NIH websites; in reports; in summaries
of the state of the science; in any possible resultant solicitation(s),
grant(s), or cooperative agreement(s); or in the development of future
funding opportunity announcements.
This RFI is for information and planning purposes only and should
not be construed as a solicitation for applications or proposals, or as
an obligation in any way on the part of the United States Federal
Government, NIH, or individual NIH Institutes, Centers, and Offices to
provide support for any ideas identified in response to it. The Federal
Government will not pay for the preparation of any information
submitted or for the Government's use of such information. No basis for
claims against the U.S. Government shall arise as a result of a
response to this RFI or from the Government's use of such information.
Additionally, the Government cannot guarantee the confidentiality of
the information provided.
Dated: November 18, 2020.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2020-26094 Filed 11-24-20; 8:45 am]
BILLING CODE 4140-01-P
